Clinical and laboratory features in acute generalized pustular psoriasis: A retrospective study of 34 patients

American Journal of Clinical Dermatology

Volumn 12, Issue 4, 2011, Pages 271-276

  Borges Costa, João ^a,b,c   Silva, Raquel ^a   Gonçalves, Luzia ^b   Filipe, Paulo ^a   Soares De Almeida, Luís ^a   Gomes, Manuel Marques ^a  

^a Clinical University of Dermatology of Lisbon   (Portugal)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^c Clínica Universitária de Dermatologia   (Portugal)

Author keywords

Acitretin, therapeutic use; Corticosteroids, therapeutic use; Etretinate, therapeutic use; Generalised pustular psoriasis; Liver disorders; Methotrexate, therapeutic use

Indexed keywords

BILIRUBIN; CORTICOSTEROID; ETRETIN; ETRETINATE; LIVER ENZYME; METHOTREXATE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HOSPITAL PATIENT; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LIVER DISEASE; MALE; MEDICAL HISTORY; MORTALITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ACUTE DISEASE; AGE OF ONSET; AGED; DERMATOLOGIC AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 79958774010     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11586900-000000000-00000     Document Type: Article

References (24)

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71 (Pubitemid 47069537)
2. Ohkawara A, Yasuda H, Kobayashi H, et al. Generalized pustular psoriasis in Japan: two distinct groups formed differences in symptoms and genetic background. Acta Derm Venereol 1996; 76: 68-71 (Pubitemid 26088625)
3. Ozawa A, Miyahara M, Sugai J, et al. HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLACw1 and HLA-DQB1. * * *0303 J Dermatol 1998; 25 (9): 573-81 (Pubitemid 28484050)
4. Iizuka H, Takahashi H, Ishida-Yamamoto A. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res 2003; 295 Suppl. 1: S55-9
5. BakerH. Corticosteroids and pustular psoriasis. Br J Dermatol 1976; 94 Suppl. 12: 83-8
6. Augey F, Renaudier P, Nicolas JF.Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol 2006; 16 (6): 669-73 (Pubitemid 46206007)
7. Ozawa A, Ohkido M, Haruki Y, et al. Treatment of generalized pustular psoriasis: a multicenter study in Japan. J Dermatol 1999; 26 (3): 141-9 (Pubitemid 29166256)
8. Baker H, Ryan TJ. Generalized pustular psoriasis: a clinical and epidemiology study of 104 cases. Br J Dermatol 1968; 80: 771-93
9. Zelickson BD, Muller SA. Generalized pustular psoriasis: a review of 63 cases. Arch Dermatol 1991; 127: 1339-45
10. Viguier M, Allez M, Zagdanski AM, et al. High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract. Hepatology 2004; 40 (2): 452-8 (Pubitemid 39062863)
11. Aronsson A, Nilsson A. Pustular psoriasis of von Zumbusch type associated with recurring cholestatic jaundice. Acta Derm Venereol 1986; 66: 164-7 (Pubitemid 16167322)
12. Chandran N, Chong WS. A dramatic response to a single dose of infliximab as rescue therapy in acute generalized pustular psoriasis of von Zumbusch associated with a neutrophilic cholangitis. Australas J Dermatol 2010; 51: 29-31
13. AusVet Animal Health Services. EpiTools epidemiological calculators [online]. Available fromURL: http://www.ausvet.com.au/epitools/ [Accessed 2011Mar 14]
14. Kardaun SH, Kuipier H, Fidler V, et al. The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J Cutan Pathol 2010; 37 (12): 1220-9
15. Ryan TJ, Baker H. Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis: evaluation and prognosis based on the study of 104 cases. Br J Dermatol 1969; 81: 134-45
16. Wolska H, Jablonska S, Langner A, et al. Etretinate therapy in generalized pustular psoriasis (Zumbusch type): immediate and long term results. Dermatologica 1985; 171 (5): 297-304 (Pubitemid 16200738)
17. BrennerM,Molin S, Ruebsam K, et al. Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment. Br J Dermatol 2009; 161: 964-6
18. Telfer NR, Dawber RP. Generalised pustular psoriasis associated with withdrawal of topical clobetasol-17-proprionate. J Am Acad Dermatol 1987; 17: 144-5 (Pubitemid 17087212)
19. Braun-Falco O, Berthold D, Ruzicka T. Psoriasis pustulosa generalisataclassification, clinical aspects and therapy: review and experiences with 18 patients [in German]. Hautarzt 1987; 38 (9): 509-20 (Pubitemid 17126545)
20. Craig JA. Jaundice in acute pustular psoriasis [letter]. Br Med J 1974; 2: 43
21. Li SPS, Tang WYM, Lam WY, et al. Renal failure and cholestatic jaundice as unusual complications of childhood pustular psoriasis. Br J Dermatol 2000; 143: 1292-6
22. Warren DJ,Winney RJ, BeveridgeGW. Oligaemia, renal failure, and jaundice associated with acute pustular psoriasis. Br Med J 1974; 2: 406-8
23. Allez M, Roux ME, Bertheau P, et al. Recurrent cholestatic jaundice associated with generalized pustular psoriasis: evidence for a neutrophilic cholangitis. J Hepatol 2000; 33: 160-2 (Pubitemid 30418949)
24. Duan H, Koga T, Kohda F, et al. Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci 2001; 26: 119-24 (Pubitemid 32510719)